Chugai Pharmaceutical Co., Ltd. (CHGCY)

OTCMKTS · Delayed Price · Currency is USD
20.64
+0.16 (0.78%)
Nov 21, 2024, 4:00 PM EST
25.78%
Market Cap 67.96B
Revenue (ttm) 7.97B
Net Income (ttm) 2.70B
Shares Out n/a
EPS (ttm) 1.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,161
Open 20.45
Previous Close 20.48
Day's Range 20.45 - 20.67
52-Week Range 14.52 - 26.00
Beta 0.53
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu,... [Read more]

Sector Healthcare
Founded 1925
Employees 7,604
Stock Exchange OTCMKTS
Ticker Symbol CHGCY
Full Company Profile

Financial Performance

In 2023, Chugai Pharmaceutical's revenue was 1.11 trillion, a decrease of -11.79% compared to the previous year's 1.26 trillion. Earnings were 325.47 billion, a decrease of -13.08%.

Financial numbers in JPY Financial Statements

News

Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market

Roche Holding AG (OTC: RHHBY) reportedly turned down a potential blockbuster weight-loss pill in 2018, allowing Eli Lilly And Co (NYSE: LLY) to acquire the drug, now known as orforglipron, for just ...

3 months ago - Benzinga

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2024 Earnings Conference Call July 24, 2024 4:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and C...

4 months ago - Seeking Alpha

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ET

7 months ago - Seeking Alpha